CAMELLIA (Cancelled)
Long-term Treatment with BELVIQ (lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects with Cardiovascular Disease or Multiple Cardiovascular Risk Factors
- Medicine
- lorcaserin HCl
- Population
- Diabetes mellitus
- Phase
- IIIb/IV
- Starting year
- 2014
- More information
- ClinicalTrials.gov